Sentinel lymph node biopsy and axillary staging of T1-T2 N0 breast cancer: A multicenter study

Seminars in Surgical Oncology

Volumn 15, Issue 4, 1998, Pages 278-283

  Sandrucci, Sergio ^a   Mussa, Antonio ^a  

^a Azienda Ospedaliera   (Italy)

Author keywords

Axilla; Biopsy; Breast neoplasms; Clinical competence; Dyes; Infiltrating direct carcinoma; Lobular carcinoma; Lymph node excision; Lymph nodes; Lymphatic metastasis; Monoclonal antibodies; Neoplasm staging; Polymerase chain reaction; Predictive value of tests; Prognosis; Radio immunodetection; Radionuclide imaging; Survival rate; Technetium Tc99m aggregated albumin; Technetium Tc99m sulfur colloid

Indexed keywords

ALBURES; DISULFINE BLUE; HUMAN ALBUMIN; NANOCOLL; NANOCOLL TC 99M; TECHNETIUM 99M; TECHNETIUM SULFUR COLLOID TC 99M; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; AXILLARY LYMPH NODE; BREAST CANCER; CANCER LOCALIZATION; CANCER STAGING; COLLOID; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 0031729946     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199812)15:4<278::AID-SSU18>3.0.CO;2-9     Document Type: Conference Paper

References (27)

1. Foster RS Jr: The biological and clinical significance of lymphatic metastases in breast cancer [Review]. Surg Oncol Clin North Am 1996;5:79-104.
2. Maunsell E, Brisson J, Deshenes L: Arm problems and psychological distress after surgery for breast cancer. Can J Surg 1993;36:315-320.
3. Hladiuk M, Huchcroft S, Temple W, Schnurr BE: Arm function after axillary dissection for breast cancer: a pilot study to provide parameter estimates. J Surg Oncol 1992;50:47-52.
4. Hoe AL, Iven D, Royle GT, Taylor I: Incidence of arm swelling following axillary clearance for breast cancer. Br J Surg 1992;79:261-262.
5. Keramopoulos A, Tsionou C, Minaretzis D, et al: Arm morbidity following treatment of breast cancer with total axillary dissection: a multivariated approach. Oncology 1993;50:445-449.
6. Cataliotti L, Distante V, Rontini M, et al: [Role of axillary dissection in breast carcinoma]. Chir Ital 1995;47:23-31 (Ita)
7. Steele RJ, Forrest AP, Gibson T, et al: The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: a controlled randomized trial Br J Surg 1985;72:368-369.
8. Kissin MW, Thompson EM, Price AB, et al: The inadequacy of axillary sampling in breast cancer Lancet 1982;1(8283):1210-1212.
9. Davies GC, Millis RR, Hayward JL: Assessment of axillary lymph node status. Ann Surg 1980;192:148-151.
10. Cabanas RM: An approach for the treatment of penile carcinoma. Cancer 1977;39:456-466.
11. Lingam MK, Mackie RM, McKay AJ: Intraoperative identification of sentinel lymph node in patients with malignant melanoma. Br J Cancer 1997;75:1505-1508.
12. Albertini JJ,Cruse CW, Rapaport D, et al: Intraoperative radiolympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996;223:217-224.
13. Veronesi U, Paganelli G, Galimberti V, et al: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes [comment in: Lancet 1997;350(9080);808-809]. Lancet 1997;349(9069):1864-1867.
14. Pijpers R, Meijer S, Hoekstra OS et al: Impact of Lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer J Nucl Med 1997;38:366-368.
15. Albertini JJ,Lyman GH, Cox C et al: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer [comment in: JAMA 1997;277:791-792]. JAMA 1996;276:1818-1822.
16. Borgstein PJ, Pijpers R, Comans EF, et al: Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintiaraphy and samma probe detection. J Am Coll Surg 1998;186:275-283.
17. Cady B, Stone MD, Schuler JG, et al: The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening [comment in: Arch Surg 1996;131:788]. Arch Surg 1996;131:301-308.
18. th annual meeting; 1998 May 16-19; Los Angeles (CA). ASCO Educational Book; Spring 1998:132-141.
19. Morton DL, Wen DR, Wong JH, et al: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
20. Alazraki NP, Eshima D, Eshima LA et al: Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers [Review]. Semin Nucl Med 1997;27:55-67.
21. Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer [comment in: Ann Surg 1997;225:125-127]. Ann Surg 1994;220:391-401.
22. Giuliano AE, Jones RC, Brennan M, Statman R: Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-2350.
23. Martin EW Jr, Tuttle SE, Rousseau M, et al: Radioimmunoguided surgery: intraoperative use of monoclonal antibody 17-1 A in colorectal cancer. Hybridoma 1986; 5 Suppl 97-108.
24. Gulec SA, Moffat FL, Carrol RG, Krag DN: Gamma probe guided sentinel node biopsy in breast cancer [Review]. Q J Nucl Med 1998;41:251-261.
25. Leak LV: Electron microscopic observations on lymphatic capillaries and the structural components of the connective tissue-lymph interface. Microvasc Res 1970;2.361-391.
26. Mustafa IA, Cole B, Wanebo HJ, et al. The impact of histopathology on nodal metastases in minimal breast cancer [Review]. Arch Surg 1997;132:384-391.
27. Krag DN, Weaver DL, Alex JC, Fairbank JT: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-340.